Delivery Order SPE2DB22D2206-SPE2DB24FFK66
Award Date
2/1/24
Potential Completion Date
2/2/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,457.72, is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract is a firm-fixed price delivery order, with a completion date of November 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the provision of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a pharmaceutical product. The potential value of this delivery order is $1,951.96, with a completion date of March 7, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a branded pharmaceutical product, with a potential value of $1,816.08 and a completion date of February 14, 2024. The contract is a firm fixed price award and does not have a set-aside designation....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication, with a ceiling value of $11,981.59 and a completion date of December 19, 2023. The contract is a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a specialty pharmaceutical product, with a potential value of $1,662.96 and a completion date of March 7, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,949.78, is for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract has an ultimate completion date of February 21, 2024 and is a Firm Fixed Price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product, with a potential value of $1,037.76 and a completion date of March 8, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization that specializes in providing pharmaceutical products and medical supplies to U.S....
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,521.63 fixed-price contract is for the delivery of MICARDIS HCT 40-12.5 mg tablets through November 30, 2023. It is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,366.20, is for the provision of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a pharmaceutical product, to support military healthcare programs. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MICARDIS HCT 40-12.5 MG Tablet UD 30S, a prescription medication, with a ceiling value of $3,455.40 and a completion date of November 20, 2023. The contract is Firm Fixed Price and has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...